{"doi":null,"coreId":"10887","oai":"oai:etheses.bham.ac.uk:1551","identifiers":["oai:etheses.bham.ac.uk:1551",null],"title":"Studies on the differentiation of inflammatory and regulatory T-cells","authors":["Jeffery, Louisa Elizabeth"],"enrichments":{"references":[{"id":406286,"title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.","authors":[],"date":"2000","doi":null,"raw":null,"cites":null}],"documentType":{"type":1}},"contributors":[],"datePublished":"2012-12","abstract":"Low vitamin D is associated with an increased risk of autoimmune diseases, whose pathology might involve T\\(_R\\)\\(_e\\)\\(_g\\) and T\\(_h\\)17 dysregulation. Thus, understanding how vitamin D modifies CD4\\(^+\\) T-cell responses holds therapeutic potential. I therefore investigated the effect of 1,25(OH)\\(_2\\)D\\(_3\\), the active form of vitamin D, upon human CD4\\(^+\\) T-cell differentiation. 1,25(OH)\\(_2\\)D\\(_3\\), acted directly upon human CD4\\(^+\\) T-cells, suppressing inflammatory cytokines (IL-17, IL-21, IFN\\(_y\\) and IL-22) whilst enhancing regulatory markers (CTLA-4, CD25, FoxP3 and IL-10). Consistently, 1,25(OH)\\(_2\\)D\\(_3\\)-treated T-cells suppressed division of naive T-cells stimulated by dendritic cells (DCs). Strong up-regulation of CTLA-4 by 1,25(OH)\\(_2\\)D\\(_3\\)reduced B7 expression by DCs, suggesting that enhanced CTLA-4 could be important mechanistically in 1,25(OH)\\(_2\\)D\\(_3\\)modified immunity. Furthermore, pro-regulatory effects of 1,25(OH)\\(_2\\)D\\(_3\\)were maintained under inflammatory conditions and modest suppression of established IL-17 by 1,25(OH)\\(_2\\)D\\(_3\\) was observed, supporting ability of 1,25(OH)\\(_2\\)D\\(_3\\)to control T-cell phenotype at inflammatory sites. DCs could also efficiently convert 25(OH)D\\(_3\\)to drive 1,25(OH)\\(_2\\)D\\(_3\\)-modified T-cell responses, which might be important in-vivo, given the low level of 1,25(OH)\\(_2\\)D\\(_3\\)in serum. Whether dysregulation of the T\\(_R\\)\\(_e\\)\\(_g\\)\/T17 balance or response to 1,25(OH)\\(_2\\)D\\(_3\\) was associated with disease outcome in early synovitis patients was also studied. Although the TReg\/T17 ratio did not stratify with outcome, T-cell responses to 1,25(OH)\\(_2\\)D\\(_3\\) were observed in all patients, suggesting that their VDR signalling is intact and that 1,25(OH)\\(_2\\)D\\(_3\\)might be useful in the treatment of synovitis","downloadUrl":"https:\/\/core.ac.uk\/download\/pdf\/10887.pdf","fullTextIdentifier":"http:\/\/etheses.bham.ac.uk\/1551\/11\/Jeffery_12_PhD.pdf","pdfHashValue":"45a8fbe1815ee2491d71fd460b1bb22a59ffe0eb","publisher":null,"rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:etheses.bham.ac.uk:1551<\/identifier><datestamp>\n      2013-03-21T09:39:05Z<\/datestamp><setSpec>\n      7374617475733D756E707562<\/setSpec><setSpec>\n      7375626A656374733D52:5243<\/setSpec><setSpec>\n      7375626A656374733D52:5241<\/setSpec><setSpec>\n      74797065733D746865736973<\/setSpec><\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n    \n      \n        Studies on the differentiation of inflammatory and regulatory T-cells<\/dc:title><dc:creator>\n        Jeffery, Louisa Elizabeth<\/dc:creator><dc:subject>\n        RC Internal medicine<\/dc:subject><dc:subject>\n        RA Public aspects of medicine<\/dc:subject><dc:description>\n        Low vitamin D is associated with an increased risk of autoimmune diseases, whose pathology might involve T\\(_R\\)\\(_e\\)\\(_g\\) and T\\(_h\\)17 dysregulation. Thus, understanding how vitamin D modifies CD4\\(^+\\) T-cell responses holds therapeutic potential. I therefore investigated the effect of 1,25(OH)\\(_2\\)D\\(_3\\), the active form of vitamin D, upon human CD4\\(^+\\) T-cell differentiation. 1,25(OH)\\(_2\\)D\\(_3\\), acted directly upon human CD4\\(^+\\) T-cells, suppressing inflammatory cytokines (IL-17, IL-21, IFN\\(_y\\) and IL-22) whilst enhancing regulatory markers (CTLA-4, CD25, FoxP3 and IL-10). Consistently, 1,25(OH)\\(_2\\)D\\(_3\\)-treated T-cells suppressed division of naive T-cells stimulated by dendritic cells (DCs). Strong up-regulation of CTLA-4 by 1,25(OH)\\(_2\\)D\\(_3\\)reduced B7 expression by DCs, suggesting that enhanced CTLA-4 could be important mechanistically in 1,25(OH)\\(_2\\)D\\(_3\\)modified immunity. Furthermore, pro-regulatory effects of 1,25(OH)\\(_2\\)D\\(_3\\)were maintained under inflammatory conditions and modest suppression of established IL-17 by 1,25(OH)\\(_2\\)D\\(_3\\) was observed, supporting ability of 1,25(OH)\\(_2\\)D\\(_3\\)to control T-cell phenotype at inflammatory sites. DCs could also efficiently convert 25(OH)D\\(_3\\)to drive 1,25(OH)\\(_2\\)D\\(_3\\)-modified T-cell responses, which might be important in-vivo, given the low level of 1,25(OH)\\(_2\\)D\\(_3\\)in serum. Whether dysregulation of the T\\(_R\\)\\(_e\\)\\(_g\\)\/T17 balance or response to 1,25(OH)\\(_2\\)D\\(_3\\) was associated with disease outcome in early synovitis patients was also studied. Although the TReg\/T17 ratio did not stratify with outcome, T-cell responses to 1,25(OH)\\(_2\\)D\\(_3\\) were observed in all patients, suggesting that their VDR signalling is intact and that 1,25(OH)\\(_2\\)D\\(_3\\)might be useful in the treatment of synovitis.<\/dc:description><dc:contributor.advisor>\n        Sansom, David<\/dc:contributor.advisor><dc:contributor.advisor>\n        Raza, Karim<\/dc:contributor.advisor><dc:date>\n        2012-12<\/dc:date><dc:type>\n        Thesis<\/dc:type><dc:type>\n        NonPeerReviewed<\/dc:type><dc:format>\n        application\/pdf<\/dc:format><dc:identifier>\n        http:\/\/etheses.bham.ac.uk\/1551\/11\/Jeffery_12_PhD.pdf<\/dc:identifier><dc:relation>\n        public<\/dc:relation><dc:relation>\n        http:\/\/etheses.bham.ac.uk\/1551\/11.hassmallThumbnailVersion\/Jeffery_12_PhD.pdf<\/dc:relation><dc:identifier>\n        Jeffery, Louisa Elizabeth (2012) Studies on the differentiation of inflammatory and regulatory T-cells. Ph.D. thesis, University of Birmingham.<\/dc:identifier><dc:relation>\n        http:\/\/etheses.bham.ac.uk\/1551\/<\/dc:relation><dc:language>\n        English<\/dc:language><dc:contributor.sponsor>\n        Arthritis Research UK.<\/dc:contributor.sponsor><\/oai_dc:dc><\/metadata><\/record>","journals":null,"language":{"code":"en","id":9,"name":"English"},"relations":["public","http:\/\/etheses.bham.ac.uk\/1551\/11.hassmallThumbnailVersion\/Jeffery_12_PhD.pdf","http:\/\/etheses.bham.ac.uk\/1551\/"],"year":2012,"topics":["RC Internal medicine","RA Public aspects of medicine"],"subject":["Thesis","NonPeerReviewed"],"fullText":""}